Achieve Life Sciences, Inc. (ACHV) Stock Grade

About Achieve Life Sciences, Inc.'s fundamentals

Achieve Life Sciences is a biotechnology company with a market capitalization of $216.7M that reported flat revenue with zero year-over-year growth and a net loss in its latest annual period, resulting in a 0% net margin. The company does not currently pay a dividend, and traditional valuation metrics like P/E ratio and return on equity are not applicable due to its unprofitable status. As a pre-revenue or early-stage biotech firm, the company's financial performance reflects the typical profile of development-stage biotechnology companies that prioritize research and development spending over profitability.